Results 111 to 120 of about 918,244 (327)
Changing the Surgical Approach to Breast Diseases During the COVID-19 Pandemic Period. [PDF]
Cureus, 2023 Gur HU, Degerli MS.
europepmc +1 more source
Molecular Oncology, EarlyView.Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi +12 more
wiley +1 more source
Hyperprolactinaemia is common in Chinese premenopausal women with breast diseases. [PDF]
Front Genet, 2023 Zhu J +11 more
europepmc +1 more source
A Clinical Lecture on Diseases of the Breast: Delivered at the Middlesex Hospital [PDF]
, 1895 A. J. Clark
openalex +1 more source
Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs
Molecular Oncology, EarlyView.In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza +3 more
wiley +1 more source
The Benefits and Concerns of Veganism in Women\u27s Health [PDF]
, 2017 There are many health benefits of consuming a vegan diet. It is associated with a decreased incidence of obesity, cardiovascular disease, type two diabetes, and a variety of cancers. Despite its numerous benefits, there are several concerns for consumers
Hester, Elisa R
core +1 more source
Clinical Lecture on the Common Diseases of the Breast [PDF]
, 1889 Christopher H. Heath
openalex +1 more source
Molecular Oncology, EarlyView.RKIP, a metastasis suppressor protein, modulates key oncogenic pathways in lung adenocarcinoma. In silico analyses linked low RKIP expression to poor survival. Functional studies revealed RKIP overexpression reduces tumor aggressiveness and enhances sensitivity to EGFR‐targeted therapies, while its loss promotes resistance.
Ana Raquel‐Cunha +10 more
wiley +1 more source